Press release
Gastric Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | BeiGene, Hutchison MediPharma, Astellas Pharma, Hubro Therapeutics
DelveInsight's "Gastric Cancer Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Gastric Cancer, historical and forecasted epidemiology as well as the Gastric Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Gastric Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gastric Cancer Market Forecast [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Gastric Cancer Market Report:
* The Gastric Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* In May 2023, CARsgen Therapeutics, a Chinese biotech firm, initiated a Phase II clinical study of CT041 in the United States. This trial is enrolling participants with advanced gastric cancer or gastroesophageal junction cancer who test positive for Claudin18.2 (CLDN18.2). CT041 is a candidate autologous chimeric antigen receptor (CAR) T-cell therapy designed to target the CLDN18.2 protein.
* The American Cancer Society's projections for gastric cancer in the United States in 2022 indicate approximately 26,380 new cases, comprising 15,900 in men and 10,480 in women. Additionally, it estimates around 11,090 deaths attributed to this form of cancer, with 6,690 among men and 4,400 among women.
* Among the 7MM, Japan (135,592 cases in 2021) has the highest and UK (6,682 cases in 2021) has the lowest number of incident cases of Gastric Cancer
* In the EU4 and the UK nations, Italy has the highest incidence rate at 24.7 per 100,000, trailed by Spain (23.1), Germany (21.6), France (17.0), and the UK (14.2).
* Key Gastric Cancer Companies: Hubro Therapeutics, Cello Therapeutics, Idience, Leap Therapeutics, Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma, Henlix Biotech, Jiangsu Hengrui Medicine, Neovii Biotech, Genmab/Janssen Biotech, Rapa Therapeutics LLC, HiberCell, Inc., and others
* Key Gastric Cancer Therapies: FMPV-1, CE008, Venadaparib, DKN-01, Abemaciclib, Tislelizumab, Fruquintinib, Zolbetuximab, HLX10, Camrelizumab, Catumaxomab, Amivantamab, RAPA-201, HC 5404 FU, and others
* The Gastric Cancer epidemiology based on gender analyzed that gastric cancer is 2.2 times more likely to be diagnosed in males than females
* The Gastric Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gastric Cancer pipeline products will significantly revolutionize the Gastric Cancer market dynamics.
Gastric Cancer Overview
Gastric cancer, also known as stomach cancer, refers to the development of malignant tumors in the lining of the stomach. It typically begins in the innermost layer of the stomach wall and can gradually spread to other layers and nearby organs if not diagnosed and treated early. Gastric cancer is often asymptomatic in its early stages, making it challenging to detect, but as it progresses, symptoms may include indigestion, abdominal discomfort or pain, nausea, vomiting, unintentional weight loss, and blood in the stool.
Get a Free sample for the Gastric Cancer Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/gastric-cancer-market [https://www.delveinsight.com/report-store/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Gastric Cancer Epidemiology Segmentation:
The Gastric Cancer market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Gastric Cancer
* Prevalent Cases of Gastric Cancer by severity
* Gender-specific Prevalence of Gastric Cancer
* Diagnosed Cases of Episodic and Chronic Gastric Cancer
Download the report to understand which factors are driving Gastric Cancer epidemiology trends @ Gastric Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastric Cancer market or expected to get launched during the study period. The analysis covers Gastric Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Gastric Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Gastric Cancer Therapies and Key Companies
* FMPV-1: Hubro Therapeutics
* CE008: Cello Therapeutics
* Venadaparib: Idience
* DKN-01: Leap Therapeutics
* Abemaciclib: Eli Lilly and Company
* Tislelizumab : BeiGene
* Fruquintinib: Hutchison MediPharma
* Zolbetuximab: Astellas Pharma
* HLX10: Henlix Biotech
* Camrelizumab: Jiangsu Hengrui Medicine
* Catumaxomab: Neovii Biotech
* Amivantamab: Genmab/Janssen Biotech
* RAPA-201: Rapa Therapeutics LLC
* HC 5404 FU: HiberCell, Inc.
Discover more about therapies set to grab major Gastric Cancer market share @ Gastric Cancer Treatment Landscape [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Market Strengths
* In-depth understanding of molecular heterogeneity of tumor and pathogenesis
* Scientific advances and identification of novel therapeutic targets for treatment
Gastric Cancer Market Opportunities
* Future development of potential biomarkers may improve screening and early detection of gastric cancers, with better accuracy, in the future.
* Increase in the awareness of gastric cancers and encouraging regular screening.
Scope of the Gastric Cancer Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Gastric Cancer Companies: Hubro Therapeutics, Cello Therapeutics, Idience, Leap Therapeutics, Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma, Henlix Biotech, Jiangsu Hengrui Medicine, Neovii Biotech, Genmab/Janssen Biotech, Rapa Therapeutics LLC, HiberCell, Inc., and others
* Key Gastric Cancer Therapies: FMPV-1, CE008, Venadaparib, DKN-01, Abemaciclib, Tislelizumab, Fruquintinib, Zolbetuximab, HLX10, Camrelizumab, Catumaxomab, Amivantamab, RAPA-201, HC 5404 FU, and others
* Gastric Cancer Therapeutic Assessment: Gastric Cancer current marketed and Gastric Cancer emerging therapies
* Gastric Cancer Market Dynamics: Gastric Cancer market drivers and Gastric Cancer market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Gastric Cancer Unmet Needs, KOL's views, Analyst's views, Gastric Cancer Market Access and Reimbursement
To know more about Gastric Cancer companies working in the treatment market, visit @ Gastric Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Gastric Cancer Market Report Introduction
2. Executive Summary for Gastric Cancer
3. SWOT analysis of Gastric Cancer
4. Gastric Cancer Patient Share (%) Overview at a Glance
5. Gastric Cancer Market Overview at a Glance
6. Gastric Cancer Disease Background and Overview
7. Gastric Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Gastric Cancer
9. Gastric Cancer Current Treatment and Medical Practices
10. Gastric Cancer Unmet Needs
11. Gastric Cancer Emerging Therapies
12. Gastric Cancer Market Outlook
13. Country-Wise Gastric Cancer Market Analysis (2019-2032)
14. Gastric Cancer Market Access and Reimbursement of Therapies
15. Gastric Cancer Market Drivers
16. Gastric Cancer Market Barriers
17. Gastric Cancer Appendix
18. Gastric Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gastric-cancer-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-states-delveinsight-beigene-hutchison-medipharma-astellas-pharma-hubro-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | BeiGene, Hutchison MediPharma, Astellas Pharma, Hubro Therapeutics here
News-ID: 3467671 • Views: …
More Releases from ABNewswire
Type 1 Diabetes Pipeline 2025: Comprehensive Clinical Trials and Therapies Analy …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Type 1 Diabetes pipeline constitutes 85+ key companies continuously working towards developing 100+ Type 1 Diabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Type 1 Diabetes Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Type 1 Diabetes Market.
The…
SendTurtle Launches Perks Platform to Help Sales Teams, Consultants, and Founder …
New marketplace inside SendTurtle provides discounted SaaS tools and personalized matching service to support growth and efficiency.
ARLINGTON, VA - September 4, 2025 - SendTurtle, the secure document sharing and analytics platform built for sales managers, consultants, and founders, today announced the launch of SendTurtle Perks, a new marketplace designed to help businesses access discounted SaaS platforms that drive growth and efficiency. Available directly inside the SendTurtle app, Perks offers exclusive…
Local Generator Company Nathan Snyder Electric LLC Strengthens Emergency Power S …
Nathan Snyder Electric LLC has expanded its emergency power services in Calumet and surrounding Oklahoma areas, offering 24/7 support, faster response times, and more technicians for generator installations and maintenance.
Nathan Snyder Electric LLC announces significant enhancements to emergency power services, reinforcing the company's position as a leading provider of backup power solutions for Calumet and surrounding Oklahoma communities. The family-owned business, operating since 2002, continues to expand capabilities while maintaining…
FreeCast Launches 10 Channels from Three Angels Broadcasting Network (3ABN)
New faith channels in five different languages join FreeCast's free FAST channels.
FreeCast and Three Angels Broadcasting Network are announcing the launch of 10 new channels on FreeCast's growing lineup of free streaming channels. The collection of faith channels for the family includes in five languages: English, Spanish, French, Portuguese, and Russian. These channels join hundreds already available at no cost to FreeCast's users.
Three Angels Broadcasting Network offers a wide variety…
More Releases for Gastric
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not.
The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller…
